AUDIO INTERVIEW
Major Research Projects in Naturopathic Oncology Interview with clinician and researcher, Dugald Seely, ND, FABNO Play Now https://www.naturalmedicinejournal.com/sites/default/files/media/dugald_seely-poise-interview.mp3 Approximate listening time: 18 minutes
Tina Kaczor, ND, FABNO, recently sat down with Dugald Seely, ND, MSc, FABNO, director of the Ottawa Integrative Cancer Centre, to discuss several ongoing studies in integrative oncology. Studying integrative oncology has unique study design challenges. They talked about how these challenges are met and how current study designs are attempting to accurately reflect complex in-office care. Seely covered a broad range of topics, from details of specific studies to an overview of the current landscape of collaborating with peers in integrative oncology. He also offered some tips on how private practice clinicians can begin to participate in research.
THE THORACIC POISE TRIAL One of Seely’s current research endeavors is the Thoracic PeriOperative Integrative Surgical Care Evaluation (POISE) Trial. Seely says it’s probably the most interesting and complex study his team is currently working on. The goal of this trial is to explore the impact of naturopathic medicine in addition to conventional usual care at the hospital for patients who have thoracic cancers and are eligible for surgery. The researchers are randomizing a group of these patients into receiving standard usual care at the hospital only, or getting usual care plus an integrated approach delivered by a naturopathic doctor before surgery and for a year after surgery. They’ll be looking at a whole battery of different outcomes, including adverse events related to surgery, quality-of-life measures, immune function, inflammatory changes, cost-effectiveness, and, ultimately, long-term survival and recurrence rate over 5 years.
DON’T MISS OUT Click here to subscribe and be sure you receive every issue http://eepurl.com/d6zXb of the Natural Medicine Journal.
30 ©2017 NATURAL MEDICINE JOURNAL. ALL RIGHTS RESERVED. NMJ, NOVEMBER 2017 SUPPLEMENT—VOL. 9, NO. 111 (SUPPL)